|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| C07K 16/22 | (2006.01) | ||
| A61P 19/10 | (2006.01) |
| (11) | Number of the document | 3774879 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19722273.0 |
| Date of filing the European patent application | 2019-03-29 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2026-01-28 |
| (46) | Date of publication of the claims translation | 2026-04-10 |
| (86) | Number | PCT/US2019/024739 |
| Date | 2019-03-29 |
| (87) | Number | WO 2019/191534 |
| Date | 2019-10-03 |
| (30) | Number | Date | Country code |
| 201862650762 P | 2018-03-30 | US | |
| 201962812741 P | 2019-03-01 | US |
| (72) |
HUANG, Zhe , US
STEVENS, Jennitte, LeAnn , US
FLYNN, Gregory , US
FODOR, Szilan , US
DARIS, Mark , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnų C-galo variantai |
| C-TERMINAL ANTIBODY VARIANTS |
| Payment date | Validity (years) | Amount | |
| 2026-02-26 | 8 | 185.00 EUR |
| 2027-03-29 |